Octaplas
Payments companies reported to CMS as associated with Octaplas. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Octaplas, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Octaplas
These are the largest totals companies reported as associated with Octaplas. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Ward | San Diego, CA | Internal Medicine | $10,000.00 |
| Melissa Cushing | New York, NY | Clinical Pathology/Laboratory Medicine | $6,789.96 |
| Steven Lee | Aptos, CA | Anesthesiology | $71.18 |
| Blessing Nwosu | Monroe, MI | Anesthesiology | $35.59 |
| Siyavash Fooladian | Orange, CA | Anesthesiology | $35.59 |
| Michael Flashburg | Long Branch, NJ | Anesthesiology | $35.59 |
| Marc Silberberg | Germantown, TN | Anesthesiology | $35.59 |
| Aymen Alian | New Haven, CT | Anesthesiology | $35.59 |
| Mark Chen | Upland, CA | Anesthesiology | $35.59 |
| Waheed Eraky | Long Branch, NJ | Anesthesiology | $35.59 |
Prescribed Octaplas?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.